Epidemiology and Management of Diverticular Disease of the Colon

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.4, 2004-01, pp. : 211-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mesalazine for diverticular disease of the colon – a new role for an old drug

By Tursi Antonio

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 69-74

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology and Management of Kawasaki Disease

By Luca Nadia J.C. Yeung Rae S.M.

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1029-1038

Adis International

Access to resources Recommend Favorite

Mesalazine and Lactobacillus casei, alone or in combination, prevent recurrence of symptomatic uncomplicated diverticular colon disease

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Tangier Disease: Epidemiology, Pathophysiology, and Management

By Puntoni Mariarita

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 303-311

Adis International

Access to resources Recommend Favorite

Lafora Disease: Epidemiology, Pathophysiology and Management

By Monaghan Thomas S. Delanty Norman

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 549-561

Adis International

Access to resources Recommend Favorite